FRCPath Haem Part 1 MCQ-Oncology 329

A 41-year-old patient with MRD-positive B-ALL receives blinatumomab and achieves complete molecular remission. What is the recommended next step?

• Observation only
• Maintenance therapy without SCT
• Proceed to allogeneic SCT if eligible
• Repeat blinatumomab indefinitely

See All Options

Want to read more?

Subscribe to hematomorph.com to keep reading this exclusive post.

Subscribe Now